SGRY NASDAQ
Surgery Partners, Inc.
1W: -7.5%
1M: -4.7%
3M: -21.6%
YTD: -12.7%
1Y: -37.1%
3Y: -52.9%
5Y: -68.3%
$13.32
+0.09 (+0.68%)
Weekly Expected Move ±10.4%
$11
$12
$13
$15
$16
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
4 relationships4
As Filer
counterparties named
0
As Counterparty
mentioned by others
2
Rel. Types
2022-11-22
Earliest Filing
2022-11-22
Latest Filing
investor: 2
partner: 2
Counterparties (Filed by SGRY)
4 relationshipsCompanies named in SGRY's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Bain Capital | BCSF | investor | Private placement investor purchasing up to 9,183,673 shares of common stock | 2022-11-22 | View |
| Barclays Capital Inc. | BCLYF | partner | Underwriter acting as representative in the public offering | 2022-11-22 | View |
| Jefferies LLC | JEF | partner | Underwriter acting as representative in the public offering | 2022-11-22 | View |
| Bain Capital Fund XI, L.P. | — | investor | Counterparty to the securities purchase agreement for the private placement | 2022-11-22 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-09-17 | Acquisition/Disposition; Exhibits | Acquisition | View |
| 2026-08-10 | Earnings Release; Exhibits | View | |
| 2026-07-24 | Material Agreement; Regulation FD; Exhibits | Agreement | View |
| 2026-06-05 | Shareholder Vote | View | |
| 2026-05-05 | Earnings Release; Exhibits | View | |
| 2026-03-02 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-12-16 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Financial Stateme | Agreement | View |
| 2025-12-12 | Other Events; Financial Statements and Exhibits | View | |
| 2025-12-11 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-11-12 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2025-11-10 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-09-16 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-08-13 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Financial Stateme | Agreement | View |
| 2025-08-06 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-08-05 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-06-17 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-06-06 | Departure/Election of Directors; Appointment of Officers; Submission of Matters to a Vote of Securit | View | |
| 2025-05-12 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-03-03 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-01-28 | Other Events; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR